Companies Aveanna Healthcare Holdings
Aveanna Healthcare (AVAH): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Aveanna Healthcare Holdings’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers33rd pct.Of 15 peer CEOs
CEO pay, last three years
- $4,864,165FY2025
CEO total pay was $4,864,165 in fiscal 2025; the brief holds no earlier figure for this CEO.
FY2025: salary $750,000 · bonus $0 · stock awards $2,603,993 · option awards $0
Executives and directors
Ed Reisz · Chief Administrative OfficerJeffrey Shaner · CEOMatthew Buckhalter · CFOBrent Layton · Independent DirectorChristopher R. Gordon · Former director (through FY2025)Devin O'Reilly · DirectorErica Schwartz · Independent DirectorRobert M. Williams, Jr · Former director (through FY2025)Rodney D. Windley · Chair of the BoardSam Weil · Independent DirectorSheldon M. Retchin · Former director (through FY2025)Steven E. Rodgers · Independent DirectorVictor F. Ganzi · Independent Director
Frequently asked questions
Who was the highest-paid executive at Aveanna Healthcare Holdings in fiscal 2025?
As disclosed, Jeffrey Shaner (President and Chief Executive Officer) was the highest-paid executive at Aveanna Healthcare Holdings in fiscal 2025, with total compensation of $4,864,165.
How does Aveanna Healthcare Holdings's chief executive pay compare to its disclosed peer group?
As disclosed, Jeffrey Shaner's total compensation ranked at the 33rd percentile of Aveanna Healthcare Holdings's disclosed peer group.
How did shareholders vote on Aveanna Healthcare Holdings's executive compensation?
As disclosed, 89.12% of shareholders supported Aveanna Healthcare Holdings's executive compensation in the latest say-on-pay vote.
How much does Aveanna Healthcare Holdings spend in total on board compensation for fiscal 2025?
As disclosed, Aveanna Healthcare Holdings reported total board compensation of $1,251,500 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Jeffrey Shaner | $750,000 | $0 | $2,603,993 | $0 | $1,500,000 | $0 | $10,172 | $4,864,165 |
| President and Chief Executive Officer | ||||||||
| Ed Reisz | 450,000 | 0 | 836,443 | 0 | 675,000 | 0 | 9,582 | 1,971,025 |
| Chief Administrative Officer | ||||||||
| Matthew Buckhalter | 468,750 | 0 | 701,499 | 0 | 750,000 | 0 | 10,065 | 1,930,314 |
| Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Jeffrey Shaner | $4,864,165 | — | — | — |
| Ed Reisz | 1,971,025 | 1,637,947 | 1,871,888 | ↑ +333,078 |
| Matthew Buckhalter | 1,930,314 | 1,703,487 | — | ↑ +226,827 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Our executive compensation program is intended to attract and retain executive officers and to align the interests of our executive officers with those of our stockholders. The Compensation Committee's objectives for our programs include, but are not limited to, the following: offer competitive total compensation opportunities, reflecting industry standards, and balance the need for talent with reasonable compensation expense; enhance stockholder value by focusing management on financial metrics that drive value; emphasize at-risk compensation versus fixed compensation; attract, motivate and retain executive talent willing to commit to long-term stockholder value creation; and discourage excessive risk taking.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Aon Human Capital Solutions (division of Aon plc) |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Jeffrey Shaner | PSU | — | — | — | — | — | $2,603,993 |
| Matthew Buckhalter | PSU | — | — | — | — | — | 701,499 |
| Ed Reisz | PSU | — | — | — | — | — | 836,443 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Jeffrey Shaner | $0 | $2,603,993 | $0 | 100.0% |
| Matthew Buckhalter | 0 | 701,499 | 0 | 100.0% |
| Ed Reisz | 0 | 836,443 | 0 | 100.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Matthew Buckhalter | RSU | 15,213 | — | $122,921 |
| Matthew Buckhalter | Option | 21,297 | 4.88 | — |
| Matthew Buckhalter | Option | 30,750 | 15 | — |
| Ed Reisz | PSU | 41,452 | — | 334,934 |
| Matthew Buckhalter | PSU | 49,915 | — | 403,316 |
| Ed Reisz | RSU | 50,304 | — | 406,456 |
| Ed Reisz | Option | 51,250 | 15 | — |
| Matthew Buckhalter | PSU | 52,357 | — | 423,045 |
| Ed Reisz | PSU | 57,094 | — | 461,320 |
| Matthew Buckhalter | RSU | 93,750 | — | 757,500 |
| Matthew Buckhalter | RSU | 104,708 | — | 846,041 |
| Ed Reisz | RSU | 114,102 | — | 921,944 |
| Shaner | RSU | 136,663 | — | 1,104,237 |
| Shaner | PSU | 172,545 | — | 1,394,163 |
| Shaner | PSU | 180,987 | — | 1,462,375 |
| Ed Reisz | RSU | 207,511 | — | 1,676,688 |
| Matthew Buckhalter | RSU | 249,878 | — | 2,019,011 |
| Shaner | RSU | 361,948 | — | 2,924,540 |
| Ed Reisz | RSU | 375,000 | — | 3,030,000 |
| Ed Reisz | Option | 709,870 | 4.88 | — |
| Shaner | RSU | 842,188 | — | 6,804,879 |
| Shaner | RSU | 863,762 | — | 6,979,197 |
| Shaner | Option | 1,206,778 | 4.88 | — |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Rodney D. WindleyIndependent · Board Chair · Nominating and Corporate Governance (Chair) | $102,000 | $150,000 | $0 | $0 | $0 | $252,000 |
| Victor F. GanziIndependent · Audit (Chair) | 95,000 | 130,000 | 0 | 0 | 0 | 225,000 |
| Steven E. RodgersIndependent · Audit · Compensation | 90,000 | 130,000 | 0 | 0 | 0 | 220,000 |
| Brent LaytonIndependent · Audit | 82,500 | 130,000 | 0 | 0 | 0 | 212,500 |
| Erica SchwartzIndependent · Clinical Quality (Chair) | 82,000 | 130,000 | 0 | 0 | 0 | 212,000 |
| Sheldon M. RetchinIndependent · Clinical Quality (Chair) · Audit · Departed during FY | — | 130,000 | 0 | 0 | 0 | 130,000 |
| Robert M. Williams, JrIndependent · Departed during FY | 0 | 0 | 0 | 0 | 0 | 0 |
| Sam WeilIndependent · Compensation · Partial-year service · Newly elected | 0 | 0 | 0 | 0 | 0 | 0 |
| Jeff ShanerEmployee director · Nominating and Corporate Governance · Clinical Quality | 0 | 0 | 0 | — | 0 | 0 |
| Devin O'Reilly | 0 | 0 | 0 | 0 | 0 | 0 |
| Christopher R. GordonIndependent · Compensation · Departed during FY | 0 | 0 | 0 | 0 | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $70,000 |
|---|---|
| Annual equity retainer | $130,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 15,000 / 12,000 |
| Stock ownership guideline | 4x annual cash retainer |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $451,500 |
| Equity awards (grant-date value) | $800,000 |
| All other compensation | $0 |
| Total cost of the board | $1,251,500 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Aveanna Healthcare as a peer
Companies that benchmark against AVAH
7 companies name AVAH as a compensation peer
- Addus HomeCare CorpADUSFY2025
- Brookdale Senior Living Inc.BKDFY2025
- DocGo Inc.DCGOFY2025
- Pediatrix Medical Group, Inc.MDFY2025
- Pennant Group, Inc.PNTGFY2025
- RadNet, Inc.RDNTFY2025
- Teladoc Health, Inc.TDOCFY2025
Each company listed discloses AVAH in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named AVAH in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
ACHC Acadia Healthcare Company, Inc. Adapt HealthADUS Addus HomeCare CorporationAMED Amedisys, Inc.AMN AMN Healthcare Services, Inc.EHAB Enhabit, Inc.NHC National HealthCare CorporationOPCH Option Care Health, Inc.MD Pediatrix Medical Group, Inc.SGRY Surgery Partners, Inc.PNTG The Pennant Group, Inc.CCRN Cross Country Healthcare, Inc.CHE Chemed CorporationRDNT RadNet, Inc.BKD Brookdale Senior Living
Peer reciprocity
Of the companies Aveanna Healthcare Holdings names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
— Acadia Healthcare Company, Inc. (ACHC)81✓ Addus HomeCare Corporation (ADUS)82 Amedisys, Inc. (AMED)— AMN Healthcare Services, Inc. (AMN)83— Enhabit, Inc. (EHAB)84 National HealthCare Corporation (NHC)— Option Care Health, Inc. (OPCH)85 Pediatrix Medical Group, Inc. (MD)— Surgery Partners, Inc. (SGRY)86✓ The Pennant Group, Inc. (PNTG)87— Cross Country Healthcare, Inc. (CCRN)88— Chemed Corporation (CHE)89✓ RadNet, Inc. (RDNT)90✓ Brookdale Senior Living (BKD)91
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Aveanna Healthcare Holdings.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Pediatrix Medical Group, Inc. | 2025 | Mark Ordan | $970,014 | $8,456,024 | $0 | $2,700,000 | $14,140,217 |
| 2 | Chemed Corporation | 2025 | Kevin McNamara | 1,858,792 | 2,883,553 | 5,036,021 | 1,486,976 | 12,904,720 |
| 3 | Addus HomeCare Corporation | 2025 | R. Dirk Allison | 1,076,923 | 9,767,870 | 0 | 1,320,000 | 12,190,449 |
| 4 | RadNet, Inc. | 2025 | Howard Berger | 3,000,000 | 8,999,966 | 0 | 0 | 12,087,934 |
| 5 | AMN Healthcare Services, Inc. | 2025 | Cary Grace | 1,060,000 | 8,363,117 | 0 | 1,146,125 | 10,669,780 |
| 6 | Option Care Health, Inc. | 2025 | John Rademacher | 1,000,000 | 6,500,050 | 0 | 1,665,000 | 9,266,330 |
| 7 | Acadia Healthcare Company, Inc. | 2025 | Christopher Hunter | 1,061,000 | 5,712,012 | 0 | 1,135,270 | 7,909,463 |
| 8 | Surgery Partners, Inc. | 2025 | J. Eric Evans | 1,050,000 | 5,000,000 | 0 | 0 | 6,083,862 |
| 9 | Brookdale Senior Living | 2025 | Nikolas Stengle | 229,310 | 4,283,968 | 0 | 403,571 | 5,307,655 |
| 10 | Aveanna Healthcare Holdings | 2025 | Jeffrey Shaner | 750,000 | 2,603,993 | 0 | 1,500,000 | 4,864,165 |
| 11 | The Pennant Group, Inc. | 2025 | Brent Guerisoli | 444,711 | 662,117 | 885,588 | 1,737,874 | 3,739,476 |
| 12 | Enhabit, Inc. | 2024 | Barbara Jacobsmeyer | 850,000 | 2,065,211 | 0 | 223,125 | 3,140,924 |
| 13 | National HealthCare Corporation | 2025 | Stephen Flatt | 577,000 | 505,215 | 300,481 | 1,280,000 | 2,685,370 |
| 14 | Cross Country Healthcare, Inc. | 2025 | Kevin Clark | 18,269 | 2,177,134 | 0 | 0 | 2,355,403 |
| — | Amedisys, Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Aveanna Healthcare Holdings | 200% | PSU 50 · RSU 50 | No | Aon Human Capital Solutions (division of Aon plc) |
| Acadia Healthcare Company, Inc. | 85.6% | PSU 50 · RSU 50 | No | WTW |
| Addus HomeCare Corporation | not disclosed | Restricted Stock 100 | not disclosed | FW Cook |
| Amedisys, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| AMN Healthcare Services, Inc. | 87% | not disclosed | Yes — Relative TSR | FW Cook |
| Brookdale Senior Living | 125.7% | not disclosed | No | F.W. Cook & Co., Inc. |
| Chemed Corporation | not disclosed | not disclosed | Yes — 3-Year Relative Total Shareholder Return (TSR) | Compensation Strategies, Inc. |
| Cross Country Healthcare, Inc. | 20% | RSU 60 · PSU 40 | No | Pearl Meyer |
| Enhabit, Inc. | not disclosed | PSU 60 · RSU 40 | not disclosed | Pay Governance |
| National HealthCare Corporation | not disclosed | not disclosed | not disclosed | false |
| Option Care Health, Inc. | 111% | PSU 60 · RSU 40 | No | Pearl Meyer |
| Pediatrix Medical Group, Inc. | 180% | RSU 50 · PSU 50 | No | Semler Brossy Consulting Group |
| RadNet, Inc. | not disclosed | RSU 100 | No | Pearl Meyer |
| Surgery Partners, Inc. | not disclosed | PSU 60 · Restricted Stock 40 | No | Frederic W. Cook & Co., Inc. (FW Cook) |
| The Pennant Group, Inc. | not disclosed | not disclosed | not disclosed | The Company engages periodically with a Compensation Adviser to review and advise the Compensation Committee on the Company's executive compensation. The Compensation Committee did not retain a Compensation Adviser relating to executive compensation in 2025, but did reference compensation studies performed for the Company previously. |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-05-29 | 160,094,458 | 19,490,871 | 61,105 | 89.12% | Passed |
| 2025 | 2025-05-09 | 172,450,332 | 104,610 | 22,792 | 99.93% | Passed |
| 2024 | 2024-05-16 | 169,424,014 | 119,091 | 21,953 | 99.92% | Passed |
| 2023 | 2023-05-10 | 168,402,819 | 1,910,610 | 595,313 | 98.53% | Passed |
| 2022 | 2022-05-10 | 168,013,753 | 135,088 | 494,290 | 99.63% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-05-29 | 89.12%a |
| 2025 | 2025-05-09 | 99.93%b |
| 2024 | 2024-05-16 | 99.92%c |
a. Approved under the standard stated in the filing — “If a quorum is present, abstentions will have the same effect as a vote against these proposals.”.
b. Approved under the standard stated in the filing — “If a quorum is present, abstentions will have the same effect as a vote against these proposals.”.
c. Approved under the standard stated in the filing — “If a quorum is present, abstentions will have the same effect as a vote against these proposals.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | — |
|---|---|
| CEO total compensation | — |
| Median employee compensation | — |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Patrick A. Cunningham | Chief Compliance Officer | 2026-05-20 | D | 125,000 | $8 | $948,538 | Common, open-market sale | Form 4 ↗ |
| J.H. Whitney Equity Partners VII, LLC | Greater-than-10% holder | 2026-06-03 | D | 5,842,240 | 6 | 36,455,578 | Common, indirect | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-06-03 | D | 1,047,913 | 6 | 6,538,977 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-06-03 | D | 109,847 | 6 | 685,445 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-06-03 | D | 1,047,913 | 6 | 6,538,977 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-06-03 | D | 5,842,240 | 6 | 36,455,578 | Common, indirect | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-06-03 | D | 109,847 | 6 | 685,445 | Common, indirect | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-06-03 | D | 5,842,240 | 6 | 36,455,578 | Common, indirect | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-06-24 | D | 7,648 | 8 | 61,184 | Common, indirect | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-06-24 | D | 72,963 | 8 | 583,704 | Common, indirect | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-06-24 | D | 919,389 | 8 | 7,355,112 | Common, indirect | Form 4 ↗ |
| J.H. Whitney Equity Partners VII, LLC | Greater-than-10% holder | 2026-06-24 | D | 919,389 | 8 | 7,355,112 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-06-24 | D | 7,648 | 8 | 61,184 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-06-24 | D | 72,963 | 8 | 583,704 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-06-24 | D | 919,389 | 8 | 7,355,112 | Common, indirect | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-06-30 | D | 55,121 | 8 | 441,519 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-06-30 | D | 525,844 | 8 | 4,212,010 | Common, indirect | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-06-30 | D | 525,844 | 8 | 4,212,010 | Common, indirect | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-06-30 | D | 2,419,035 | 8 | 19,376,470 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-06-30 | D | 55,121 | 8 | 441,519 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-06-30 | D | 2,419,035 | 8 | 19,376,470 | Common, indirect | Form 4 ↗ |
| J.H. Whitney Equity Partners VII, LLC | Greater-than-10% holder | 2026-06-30 | D | 2,419,035 | 8 | 19,376,470 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-08-20 | D | 1,426,034 | 12 | 16,399,391 | Common, indirect | Form 4 ↗ |
| Ed Reisz | Chief Administrative Officer | 2026-08-20 | D | 50,000 | 12 | 575,000 | Common | Form 4 ↗ |
| Jeff Shaner | Chief Executive Officer | 2026-08-20 | D | 90,000 | 12 | 1,035,000 | Common | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-08-20 | D | 190,130 | 12 | 2,186,495 | Common, indirect | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-08-20 | D | 1,813,795 | 12 | 20,858,643 | Common, indirect | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-08-20 | D | 957,918 | 12 | 11,016,057 | Common, indirect | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-08-20 | D | 10,112,125 | 12 | 116,289,438 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-08-20 | D | 957,918 | 12 | 11,016,057 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-08-20 | D | 10,112,125 | 12 | 116,289,438 | Common, indirect | Form 4 ↗ |
| J.H. Whitney Equity Partners VII, LLC | Greater-than-10% holder | 2026-08-20 | D | 957,918 | 12 | 11,016,057 | Common, indirect | Form 4 ↗ |
| J.H. Whitney Equity Partners VII, LLC | Greater-than-10% holder | 2026-08-20 | D | 10,112,125 | 12 | 116,289,438 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-08-20 | D | 1,813,795 | 12 | 20,858,643 | Common, indirect | Form 4 ↗ |
| Rodney D. Windley | Director | 2026-08-20 | D | 180,000 | 12 | 2,070,000 | Common | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-08-20 | D | 1,426,034 | 12 | 16,399,391 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-08-20 | D | 190,130 | 12 | 2,186,495 | Common, indirect | Form 4 ↗ |
| J.H. Whitney Equity Partners VII, LLC | Greater-than-10% holder | 2026-08-20 | D | 1,426,034 | 12 | 16,399,391 | Common, indirect | Form 4 ↗ |
| J.H. Whitney Equity Partners VII, LLC | Greater-than-10% holder | 2026-08-21 | D | 2,250,000 | 12 | 25,875,000 | Common, indirect | Form 4 ↗ |
| Robert M. Williams, Jr | Greater-than-10% holder | 2026-08-21 | D | 2,250,000 | 12 | 25,875,000 | Common, indirect | Form 4 ↗ |
| Paul R. Vigano | Greater-than-10% holder | 2026-08-21 | D | 2,250,000 | 12 | 25,875,000 | Common, indirect | Form 4 ↗ |
| Deborah Stewart | SVP, Chief Accounting Officer | 2026-10-01 | A | 75,000 | 0 | 0 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (91 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Jeffrey Shaner. DEF 14A, filed 2026-04-17. Section “Summary Compensation Table” · page 40. As printed: 4,864,165. View filing ↗
- Section 01, Ed Reisz. DEF 14A, filed 2026-04-17. Section “Summary Compensation Table”. As printed: 1,971,025. View filing ↗
- Section 01, Matthew Buckhalter. DEF 14A, filed 2026-04-17. Section “Summary Compensation Table”. As printed: 1,930,314. View filing ↗
- Section 03, Jeffrey Shaner PSU. DEF 14A, filed 2026-04-17. Section “REPORT OF THE COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
- Section 03, Matthew Buckhalter PSU. DEF 14A, filed 2026-04-17. Section “REPORT OF THE COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
- Section 03, Ed Reisz PSU. DEF 14A, filed 2026-04-17. Section “REPORT OF THE COMPENSATION COMMITTEE” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-17. Section “CEO Pay Ratio”. As printed: —. View filing ↗
- Section 08, Rodney D. Windley. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 252,000. View filing ↗
- Section 08, Victor F. Ganzi. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 225,000. View filing ↗
- Section 08, Steven E. Rodgers. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 220,000. View filing ↗
- Section 08, Brent Layton. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 212,500. View filing ↗
- Section 08, Erica Schwartz. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 212,000. View filing ↗
- Section 08, Sheldon M. Retchin. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 130,000. View filing ↗
- Section 08, Robert M. Williams, Jr. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Sam Weil. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Jeff Shaner. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Devin O'Reilly. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, Christopher R. Gordon. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Patrick A. Cunningham 2026-05-20. Form 4, filed 2026-05-21. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J.H. Whitney Equity Partners VII, LLC 2026-06-03. Form 4, filed 2026-06-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-06-03. Form 4, filed 2026-06-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-06-03. Form 4, filed 2026-06-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-06-03. Form 4, filed 2026-06-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-06-03. Form 4, filed 2026-06-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-06-03. Form 4, filed 2026-06-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-06-03. Form 4, filed 2026-06-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-06-24. Form 4, filed 2026-06-26. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-06-24. Form 4, filed 2026-06-26. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-06-24. Form 4, filed 2026-06-26. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J.H. Whitney Equity Partners VII, LLC 2026-06-24. Form 4, filed 2026-06-26. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-06-24. Form 4, filed 2026-06-26. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-06-24. Form 4, filed 2026-06-26. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-06-24. Form 4, filed 2026-06-26. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-06-30. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-06-30. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-06-30. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-06-30. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-06-30. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-06-30. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J.H. Whitney Equity Partners VII, LLC 2026-06-30. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ed Reisz 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jeff Shaner 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J.H. Whitney Equity Partners VII, LLC 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J.H. Whitney Equity Partners VII, LLC 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Rodney D. Windley 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J.H. Whitney Equity Partners VII, LLC 2026-08-20. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J.H. Whitney Equity Partners VII, LLC 2026-08-21. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Robert M. Williams, Jr 2026-08-21. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul R. Vigano 2026-08-21. Form 4, filed 2026-08-24. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deborah Stewart 2026-10-01. Form 4, filed 2026-10-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-05-29. Item 5.07 · say-on-pay result. As reported: 89.12% (votes for as printed: 160,094,458). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-05-09. Item 5.07 · say-on-pay result. As reported: 99.93% (votes for as printed: 172,450,332). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-05-17. Item 5.07 · say-on-pay result. As reported: 99.92% (votes for as printed: 169,424,014). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 451,500 + equity 800,000 + all other 0 = 1,251,500, summed across the director compensation table rows.
- Pediatrix Medical Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Pediatrix Medical Group, Inc.'s own proxy. As printed: 14,140,217. View filing ↗
- Chemed Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-09. CEO total compensation as printed in Chemed Corporation's own proxy. As printed: 12,904,720. View filing ↗
- Addus HomeCare Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Addus HomeCare Corporation's own proxy. As printed: 12,190,449. View filing ↗
- RadNet, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-20. CEO total compensation as printed in RadNet, Inc.'s own proxy. As printed: 12,087,934. View filing ↗
- AMN Healthcare Services, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-18. CEO total compensation as printed in AMN Healthcare Services, Inc.'s own proxy. As printed: 10,669,780. View filing ↗
- Option Care Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Option Care Health, Inc.'s own proxy. As printed: 9,266,330. View filing ↗
- Acadia Healthcare Company, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-25. CEO total compensation as printed in Acadia Healthcare Company, Inc.'s own proxy. As printed: 7,909,463. View filing ↗
- Surgery Partners, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Surgery Partners, Inc.'s own proxy. As printed: 6,083,862. View filing ↗
- Brookdale Senior Living, Section 10b CEO total. DEF 14A, filed 2026-04-30. CEO total compensation as printed in Brookdale Senior Living's own proxy. As printed: 5,307,655. View filing ↗
- Aveanna Healthcare Holdings (subject), Section 10b CEO total. DEF 14A, filed 2026-04-17. CEO total compensation as printed in Aveanna Healthcare Holdings's own proxy. As printed: 4,864,165. View filing ↗
- The Pennant Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-31. CEO total compensation as printed in The Pennant Group, Inc.'s own proxy. As printed: 3,739,476. View filing ↗
- Enhabit, Inc., Section 10b CEO total. DEF 14A, filed 2025-05-16. CEO total compensation as printed in Enhabit, Inc.'s own proxy. As printed: 3,140,924. View filing ↗
- National HealthCare Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in National HealthCare Corporation's own proxy. As printed: 2,685,370. View filing ↗
- Cross Country Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-30. CEO total compensation as printed in Cross Country Healthcare, Inc.'s own proxy. As printed: 2,355,403. View filing ↗
- Section 10a, Acadia Healthcare Company, Inc. reciprocity. DEF 14A. Acadia Healthcare Company, Inc.'s most recent proxy was read; its disclosed peer group does not include Aveanna Healthcare Holdings. View filing ↗
- Section 10a, Addus HomeCare Corporation reciprocity. DEF 14A. Addus HomeCare Corporation names Aveanna Healthcare Holdings in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, AMN Healthcare Services, Inc. reciprocity. DEF 14A. AMN Healthcare Services, Inc.'s most recent proxy was read; its disclosed peer group does not include Aveanna Healthcare Holdings. View filing ↗
- Section 10a, Enhabit, Inc. reciprocity. DEF 14A. Enhabit, Inc.'s most recent proxy was read; its disclosed peer group does not include Aveanna Healthcare Holdings. View filing ↗
- Section 10a, Option Care Health, Inc. reciprocity. DEF 14A. Option Care Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Aveanna Healthcare Holdings. View filing ↗
- Section 10a, Surgery Partners, Inc. reciprocity. DEF 14A. Surgery Partners, Inc.'s most recent proxy was read; its disclosed peer group does not include Aveanna Healthcare Holdings. View filing ↗
- Section 10a, The Pennant Group, Inc. reciprocity. DEF 14A. The Pennant Group, Inc. names Aveanna Healthcare Holdings in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Cross Country Healthcare, Inc. reciprocity. DEF 14A. Cross Country Healthcare, Inc.'s most recent proxy was read; its disclosed peer group does not include Aveanna Healthcare Holdings. View filing ↗
- Section 10a, Chemed Corporation reciprocity. DEF 14A. Chemed Corporation's most recent proxy was read; its disclosed peer group does not include Aveanna Healthcare Holdings. View filing ↗
- Section 10a, RadNet, Inc. reciprocity. DEF 14A. RadNet, Inc. names Aveanna Healthcare Holdings in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Brookdale Senior Living reciprocity. DEF 14A. Brookdale Senior Living names Aveanna Healthcare Holdings in its own disclosed peer group (read from its most recent proxy). View filing ↗